Organogenesis Holdings Inc (ORGO)
2.98
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
2.995
+0.02
(+0.50%)
After-Hours: 20:00
Organogenesis Holdings Cash from Investing (TTM): -24.36M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -24.36M |
September 30, 2023 | -31.70M |
June 30, 2023 | -36.12M |
March 31, 2023 | -34.79M |
December 31, 2022 | -33.90M |
September 30, 2022 | -28.47M |
June 30, 2022 | -34.77M |
March 31, 2022 | -32.94M |
December 31, 2021 | -31.22M |
September 30, 2021 | -31.41M |
June 30, 2021 | -26.67M |
Date | Value |
---|---|
March 31, 2021 | -24.21M |
December 31, 2020 | -23.50M |
September 30, 2020 | -21.54M |
June 30, 2020 | -10.85M |
March 31, 2020 | -10.16M |
December 31, 2019 | -6.234M |
September 30, 2019 | -3.138M |
June 30, 2019 | -2.80M |
March 31, 2019 | -2.108M |
December 31, 2018 | -1.856M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-36.12M
Minimum
Jun 2023
-2.80M
Maximum
Jun 2019
-23.62M
Average
-26.67M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |
Oragenics Inc | -0.9363M |